Longitudinal Stability of Coagulation, Fibrinolysis, and Inflammation Factors in Stored Plasma Samples

Michael R. Lewis; Peter W. Callas; Nancy S. Jenny; Russell P. Tracy

doi:10.1055/s-0037-1616754

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2001; 86(06): 1495-1500
DOI: 10.1055/s-0037-1616754

Review Article

Schattauer GmbH

Longitudinal Stability of Coagulation, Fibrinolysis, and Inflammation Factors in Stored Plasma Samples

Michael R. Lewis

¹Department of Pathology, University of Vermont College of Medicine, Burlington, VT

,

Peter W. Callas

²Biometry Facility, University of Vermont College of Medicine, Burlington, VT

,

Nancy S. Jenny

¹Department of Pathology, University of Vermont College of Medicine, Burlington, VT

,

Russell P. Tracy

¹Department of Pathology, University of Vermont College of Medicine, Burlington, VT

³Department of Biochemistry, University of Vermont College of Medicine, Burlington, VT, USA

› Institutsangaben

Abstract

Summary

We sought to assess the longitudinal stability of risk factors for atherosclerosis and thrombosis, including several coagulation, fibrinolysis, and inflammation factors, in frozen plasma samples stored at –70° C for months or years. We reviewed data collected on 29 different control pools over periods ranging from 7 to 59 months for two functional assays (factor VII and fibrinogen) and seven antigen measurements (C-reactive protein, D-dimer, plasmin-α ₂-antiplasmin complex, plasminogen activator inhibitor-1, protein C, protein S, and tissue plasminogen activator), totaling more than 15,000 data points. Screening of the data using least squares regression revealed only sporadic associations between monthly means and time, with no consistent trends. Analysis by repeated measures and summary measure methods revealed no evidence of sample degradation over time for the factors studied. Our finding of longitudinal stability in the biochemical properties of frozen plasma strengthens the presumption of sample stability on which molecular epidemiologic studies are based.

Keywords

Acute-phase proteins - atherosclerosis - blood coagulation factors - molecular epidemiology - thrombosis

Volltext

Referenzen

References
1 Winn DM, Gunter EW. Biologic specimen banks: a resource for molecular epidemiologic studies. In: Schulte PA, Perera FP. ed. Molecular Epidemiology: Principles and Practices. New York: Academic Press; 1993: 217-34.
2 Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study – I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost 1989; 61: 15-9.
3 Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 1995; 41: 264-70.
4 Hankinson SE, London SJ, Chute CG. et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989; 35: 2313-6.
5 Iversen LH, Thorlacius-Ussing O. Short-time stability of markers of coagulation and fibrinolysis in frozen plasma. Thromb Res 1996; 81: 253-61.
6 Shih WJ, Bachorik PS, Haga JA, Myers GL, Stein EA. Estimating the long-term effects of storage at –70 degrees C on cholesterol, triglyceride, and HDL-cholesterol measurements in stored sera. Clin Chem 2000; 46: 351-64.
7 Jerne NK, Perry WLM. The stability of biological standards. Bull World Health Organ 1956; 1956: 167-82.
8 Moss DW, Henderson AR. Clinical enzymology. In: Burtis CA, Ashwood ER. ed. Tietz Textbook of Clinical Chemistry. Philadephia: W. B. Saunders Company; 1999: 617-721.
9 Westgard JK, Klee GG. Quality management. In: Burtis CA, Ashwood ER. eds. Tietz Textbook of Clinical Chemistry. Philadelphia: W. B. Saunders Company; 1999: 384-418.
10 Bangham DR, Biggs R, Brozovic M, Denson KW, Skegg JL. A biological standard for measurement of blood coagulation Factor VIII activity. Bull World Health Organ 1971; 45: 337-51.
11 Go M. Clot promoting activity and activities of clotting factors in lyophilized serum. Tohoku J Exp Med 1973; 111: 137-46.
12 Strumia MMM, McGraw JJ, Heggestad GE. Preservation of dried and frozen plasma over a ten-year period. Am J Clin Pathol 1952; 22: 313-21.
13 National Committee for Clinical Laboratory Standards (NCCLS).. Source-book of reference methods, materials, and related information for the clinical laboratory; proposed guideline. Villanova, PA: NCCLS; 1994. (NCCLS publication nr. NRSCL 12-P).
14 World Health Organization (WHO). Expert Committee on Biological Standardization. Thirty-seventh report. Geneva: WHO; 1987. (WHO technical report series, nr. 760).
15 Gaffney PJ, Wong MY. Collaborative study of a proposed international standard for plasma fibrinogen measurement. Thromb Haemost 1992; 68: 428-32.
16 Gaffney PJ, Edgell TA. The international standard for plasminogen activator inhibitor-1 (PAI-1) activity. Thromb Haemost 1996; 76: 80-3.
17 Hubbard AR. Standardization of protein C in plasma: establishment of an international standard. Thromb Haemost 1988; 59: 464-7.
18 Hubbard AR. Standardisation of protein S in plasma: calibration of the 1st International Standard. Thromb Haemost 1997; 78: 1237-41.
19 Gaffney PJ, Curtis AD. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA). Thromb Haemost 1987; 58: 1085-7.
20 Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-8.
21 Declerck PJ, Mombaerts P, Holvoet P, De Mol M, Collen D. Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis. Thromb Haemost 1987; 58: 1024-9.
22 Holvoet P, de Boer A, Verstreken M, Collen D. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma – application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost 1986; 56: 124-7.
23 Declerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-5.
24 Macy EM, Meilahn EN, Declerck PJ, Tracy RP. Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies. Arch Pathol Lab Med 1993; 117: 67-70.
25 Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemost 1985; 54: 684-7.
26 Howard PR, Bovill EG, Mann KG, Tracy RP. A monoclonal-antibody-based radioimmunoassay for measurement of protein C in plasma. Clin Chem 1988; 34: 324-30.
27 Bovill EG, Landesman MM, Busch SA, Fregeau GR, Mann KG, Tracy RP. Studies on the measurement of protein S in plasma. Clin Chem 1991; 37: 1708-14.
28 Geffken DF, Keating FG, Kennedy MH, Cornell ES, Bovill EG, Tracy RP. The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology. Arch Pathol Lab Med 1994; 118: 1106-9.
29 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens (German). Acta Haematol 1957; 17: 237-46.
30 Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-7.
31 SPSS for Windows. Chicago, IL: SPSS, Inc.; 1997
32 Microsoft Excel 97. Redmond, WA: Microsoft Corporation; 1997
33 Hand D, Crowder M. Practical longitudinal data analysis. New York: Chapman & Hall; 1996
34 Greenhouse SW, Geisser S. On methods in the analysis of profile data. Psychometrika 1959; 24: 95-112.
35 Huynh H, Feldt LS. Estimation of the Box correction for degrees of freedom from sample data in randomized block and split-plot designs. J Educ Stat 1976; 1: 69-82.
36 Suissa S, Ernst P. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 1997; 50: 1079-88.
37 Donner A. Linear regression analysis with repeated measurements. J Chronic Dis 1984; 37: 441-8.
38 de Klerck NH. Repeated warnings re repeated measures (editorial). Aust N Z J Med 1986; 16: 637-8.
39 Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300: 230-5.